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Summary Melasma is one of the most frequently acquired hyperpigmentation disorders clinically
characterized by symmetrical brown patches on sun-exposed areas. To date, few
studies have been conducted about the relationship between thyroid autoimmun-
ity and melasma. To evaluate the thyroid dysfunction and autoimmunity in
nonpregnant women with melasma. A total of 70 women with melasma and 70 age-
matched healthy women with no history of melasma were enrolled in the study. We
studied the thyroid hormone proﬁle in both groups. The statistical analysis was
performed using SPSS software. Patients with melasma had 18.5% frequency of
thyroid disorders, and 15.7% had positive anti-TPO, while subjects from the control
group had a 4.3% frequency of thyroid abnormalities, and only 5.7% had positive
anti-TPO. There was a signiﬁcantly higher prevalence of thyroid dysfunction in
women with melasma compared with control group (P = 0.008). This study suggests
that there is a relationship between thyroid autoimmunity and melasma. However, to
make recommendations on screening for thyroid disease in patients with melasma,
future research of good methodological quality is needed.
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Introduction
Melasma, also known as chloasma, is a common,
acquired disorder, characterized by symmetric, hyper-
pigmented patches with an irregular outline that
affects sun-exposed areas of skin, most commonly the
face. It is most prevalent among young to middle-aged
women who are Hispanic, Asian, or of African or Mid-
dle Eastern descent, that is darker skin phototypes.1
The precise pathogenesis of melasma has not been
determined. However, multiple factors are likely to be
implicated in its etiopathogenesis, including pregnancy,
combined oral contraceptive pills (OCPs), genetics fac-
tors, sun exposure, use of cosmetic products, thyroid
dysfunction, and antiseizure medications.1–4 Melasma
in men shares the same clinico-histologic characteris-
tics as in women, but hormonal factors do not seem to
play major signiﬁcant role;5 it is not clear whether
hormonal factors play a role in men.5,6
The key role of UV radiation is supported by the fad-
ing of lesions during winter months and the distribu-
tion pattern of melasma, with the involvement of sun-
exposed sites and sparing of sites such as the philtrum.
Compared to the uninvolved adjacent skin, increased
melanin deposition is observed in all layers of the epi-
dermis. An increased number of melanin-containing
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